[On the subacute toxicity of labetalol (AH5158): a combined alpha-and beta-adrenoceptor blocking agent (author's transl)]. 1980

K Shimpo, and Y Yokoi, and S Fujiwara, and H Togashi, and T Tanabe

Subacute toxicity and recovery tests of labetalol hydrochloride, alpha- and beta-adrenoceptor blocking agent, were carried out using male and female Wistar strain rats. The drug was orally administered at 50, 150, 450 or 1000 mg/kg/day for 1 month. In all the drug-treated groups, increase in salivation was observed from immediately to 15 minutes after dosing through the treatment period. Eight of the 10 males and 9 of the 10 females in the group treated with 1000 mg/kg/day died of intoxication. Suppression of body weight gain was observed in male rats in the 450 and 1000 mg/kg/day groups and in female rats in the 1000 mg/kg/day group. In the 150 mg/kg/day and higher dose groups, water consumption showed a tendency to increase as compared with that of control group. Increase in urine volume was observed in female rats in the 450 mg/kg/day group. In the serum biochemical examination, slight elevation in potassium levels was noted in the 150 and 450 mg/kg/day groups. In histopathological findings, some abnormalities were found in the groups treated at 150 mg/kg/day and higher. Major abnormalities found in organs were; congestion and hypremia of various organs due to vasodilation, swelling of parenchymatous cells in liver and kidneys, and loose arrangement and change in the thickness of muscle fibers in cardiac and skeletal muscles. None of these abnormal findings was found in any examination in recovery tests.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007741 Labetalol A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. AH-5158,Albetol,Apo-Labetalol,Dilevalol,Labetalol Hydrochloride,Labetalol, (R,R)-Isomer,Labetolol,Normodyne,Presolol,R,R-Labetalol,SCH-19927,Trandate,AH 5158,AH5158,Apo Labetalol,ApoLabetalol,Hydrochloride, Labetalol,R,R Labetalol,SCH 19927,SCH19927
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D004326 Drinking The consumption of liquids. Water Consumption,Water Intake,Drinkings
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols
D005260 Female Females

Related Publications

K Shimpo, and Y Yokoi, and S Fujiwara, and H Togashi, and T Tanabe
January 1978, General pharmacology,
K Shimpo, and Y Yokoi, and S Fujiwara, and H Togashi, and T Tanabe
October 1984, Archives internationales de pharmacodynamie et de therapie,
K Shimpo, and Y Yokoi, and S Fujiwara, and H Togashi, and T Tanabe
April 1982, Anasthesie, Intensivtherapie, Notfallmedizin,
K Shimpo, and Y Yokoi, and S Fujiwara, and H Togashi, and T Tanabe
April 1979, British journal of clinical pharmacology,
K Shimpo, and Y Yokoi, and S Fujiwara, and H Togashi, and T Tanabe
January 1979, British journal of clinical pharmacology,
K Shimpo, and Y Yokoi, and S Fujiwara, and H Togashi, and T Tanabe
October 1982, International journal of clinical pharmacology, therapy, and toxicology,
K Shimpo, and Y Yokoi, and S Fujiwara, and H Togashi, and T Tanabe
October 1983, Annals of internal medicine,
K Shimpo, and Y Yokoi, and S Fujiwara, and H Togashi, and T Tanabe
August 1976, British journal of clinical pharmacology,
K Shimpo, and Y Yokoi, and S Fujiwara, and H Togashi, and T Tanabe
October 1976, British journal of clinical pharmacology,
K Shimpo, and Y Yokoi, and S Fujiwara, and H Togashi, and T Tanabe
April 1979, British journal of clinical pharmacology,
Copied contents to your clipboard!